RBC Capital Raises PT on Ocular Therapeutix (OCUL) to $24 Amid Solid Growth Trajectory

Ocular Therapeutix, Inc. (NASDAQ:OCUL) is one of the 15 stocks set to explode in 2026.

RBC Capital Raises PT on Ocular Therapeutix (OCUL) to $24 Amid Solid Growth Trajectory

Ikonoklast Fotografie/Shutterstock.com

On November 5, 2025, RBC Capital raised its price target on Ocular Therapeutix, Inc. (NASDAQ:OCUL) from $17 to $24, while maintaining an “Outperform” rating.

The revised target was attributed to the company’s strong execution in its SOL-1 wet age-related macular degeneration (wAMD) superiority study. The study is on a solid trajectory for a first-quarter 2026 top-line readout. The investment firm cited patient retention and adherence going past 95%, no signs of safety concerns, and excess cash reserves as key growth drivers. The cash reserves now sit at approximately $790 million following a $445 million capital raise. Furthermore, RBC Capital sees Ocular Therapeutix, Inc. (NASDAQ:OCUL) potentially gaining significant market share in both wAMD and DR segments, expecting the company’s momentum to extend into diabetic retinopathy trials.

On the other hand, on November 4, 2025, Ocular Therapeutix, Inc. (NASDAQ:OCUL) released its Q3 2025 results. The quarter marked a reaffirmation of the company’s progress in its SOL-R trial, which achieved its randomization goal of 555 subjects. The company demonstrated disciplined trial design by expanding its AXPAXLI program across retinal diseases. The company maintains a financial runway into 2028 with a cash balance of $344.8 million, excluding net proceeds of $445 million from an underwritten offering of common shares.

Ocular Therapeutix, Inc. (NASDAQ:OCUL), an integrated biopharmaceutical company, develops innovative hydrogel-based therapies for treating retinal diseases.

While we acknowledge the potential of OCUL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than OCUL and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 13 Best Fortune 500 Stocks to Invest in Now and 13 Best Fortune 500 Stocks to Invest in Now.

Disclosure: None.